These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Should cholinesterase inhibitors be used to treat Alzheimer's disease? Finucane TE; Gilstad JR Nat Clin Pract Neurol; 2006 Mar; 2(3):118-9. PubMed ID: 16932534 [No Abstract] [Full Text] [Related]
25. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381 [TBL] [Abstract][Full Text] [Related]
26. Difficult times for Alzheimer's treatments. O'Neill MF Drug Discov Today; 2005 Oct; 10(20):1333-5. PubMed ID: 16253864 [No Abstract] [Full Text] [Related]
28. [Alzheimer dementia. Main goal: improve quality of life for patients and family]. Dtsch Med Wochenschr; 1997 Apr; 122(17 Suppl):1-4. PubMed ID: 9171803 [No Abstract] [Full Text] [Related]
29. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease. Rabins PV; Lyketsos CG Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739 [No Abstract] [Full Text] [Related]
30. [Treatment of Alzheimer's disease with acetylcholinesterase inhibitors]. Dartigues JF; Poncet M Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F107. PubMed ID: 18680827 [No Abstract] [Full Text] [Related]
31. [Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety]. Richard E; van Gool WA Ned Tijdschr Geneeskd; 2006 Mar; 150(10):530-2. PubMed ID: 16566413 [TBL] [Abstract][Full Text] [Related]
34. The Alzheimer's Disease Cooperative Study in 2004. Thal LJ Alzheimer Dis Assoc Disord; 2004; 18(4):183-5. PubMed ID: 15592126 [No Abstract] [Full Text] [Related]
35. Galantamine improves gait performance in patients with Alzheimer's disease. Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755 [No Abstract] [Full Text] [Related]
36. [Administration of symptom-relieving drugs in Alzheimer disease is beneficial]. Nordberg A; Eriksdotter-Jönhagen M; Garlind A; Grut M; Freund-Levi Y; Cornelius C; Ekström A; Fastbom J; Sedvall M; Viitanen M Lakartidningen; 2006 Feb 8-14; 103(6):369-71. PubMed ID: 16536040 [No Abstract] [Full Text] [Related]
37. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease. Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161 [No Abstract] [Full Text] [Related]
38. Current status: Alzheimer's Disease. Ghosh R Kathmandu Univ Med J (KUMJ); 2003; 1(3):205-11. PubMed ID: 16388232 [No Abstract] [Full Text] [Related]
39. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. Vellas B; Lauque S; Gillette-Guyonnet S; Andrieu S; Cortes F; Nourhashémi F; Cantet C; Ousset PJ; Grandjean H; J Nutr Health Aging; 2005; 9(2):75-80. PubMed ID: 15791349 [TBL] [Abstract][Full Text] [Related]
40. Clinical inquiries. Do patients at high risk of Alzheimer's disease benefit from early treatment? Holt J; Stiltner L; Wallace R; Raetz J J Fam Pract; 2009 Jun; 58(6):320-2. PubMed ID: 19508846 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]